EP1365240A3 - Procédés, appareils et réactifs immunologiques - Google Patents

Procédés, appareils et réactifs immunologiques Download PDF

Info

Publication number
EP1365240A3
EP1365240A3 EP03011084A EP03011084A EP1365240A3 EP 1365240 A3 EP1365240 A3 EP 1365240A3 EP 03011084 A EP03011084 A EP 03011084A EP 03011084 A EP03011084 A EP 03011084A EP 1365240 A3 EP1365240 A3 EP 1365240A3
Authority
EP
European Patent Office
Prior art keywords
immunoassay
reagents
apparatuses
immunoassays
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
EP03011084A
Other languages
German (de)
English (en)
Other versions
EP1365240B1 (fr
EP1365240A2 (fr
Inventor
Yasunori Kawate
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sysmex Corp
Original Assignee
Sysmex Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sysmex Corp filed Critical Sysmex Corp
Publication of EP1365240A2 publication Critical patent/EP1365240A2/fr
Publication of EP1365240A3 publication Critical patent/EP1365240A3/fr
Application granted granted Critical
Publication of EP1365240B1 publication Critical patent/EP1365240B1/fr
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54313—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals the carrier being characterised by its particulate form
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Peptides Or Proteins (AREA)
  • Automatic Analysis And Handling Materials Therefor (AREA)
  • Investigating Or Analysing Materials By Optical Means (AREA)
  • Steroid Compounds (AREA)
EP03011084A 2002-05-22 2003-05-21 Procédés, appareils et réactifs immunologiques Expired - Lifetime EP1365240B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2002147085 2002-05-22
JP2002147085 2002-05-22

Publications (3)

Publication Number Publication Date
EP1365240A2 EP1365240A2 (fr) 2003-11-26
EP1365240A3 true EP1365240A3 (fr) 2004-01-07
EP1365240B1 EP1365240B1 (fr) 2006-09-13

Family

ID=29397846

Family Applications (1)

Application Number Title Priority Date Filing Date
EP03011084A Expired - Lifetime EP1365240B1 (fr) 2002-05-22 2003-05-21 Procédés, appareils et réactifs immunologiques

Country Status (4)

Country Link
US (1) US20030224534A1 (fr)
EP (1) EP1365240B1 (fr)
AT (1) ATE339687T1 (fr)
DE (1) DE60308259T2 (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4435581B2 (ja) * 2004-01-07 2010-03-17 シスメックス株式会社 免疫測定装置および方法
JP4805564B2 (ja) * 2004-10-22 2011-11-02 シスメックス株式会社 生体試料分析装置および方法
EP1909206A1 (fr) * 2006-09-11 2008-04-09 Roche Diagnostics GmbH Test rapide cromatographique à plage de mésure étendue
CN105699662A (zh) * 2006-11-02 2016-06-22 协和梅迪克斯株式会社 免疫测定待测组分的方法
JP4975600B2 (ja) * 2007-03-16 2012-07-11 シスメックス株式会社 Ｈｃｖ抗体測定用試薬キット及びｈｃｖ抗体測定方法
US20080227111A1 (en) 2007-03-16 2008-09-18 Sysmex Corporation Reagent kit and method for measuring hcv antibody
US7802883B2 (en) 2007-12-20 2010-09-28 Johnson & Johnson Vision Care, Inc. Cosmetic contact lenses having a sparkle effect
CN102016578B (zh) 2008-03-21 2014-10-01 艾博特健康公司 利用红细胞内含有的血红蛋白的本征色素沉着来确定血样的血细胞比容的方法及设备
CN102016686B (zh) * 2008-03-21 2015-03-25 艾博特健康公司 确定对生物样本成像的成像装置的焦点位置的方法和设备
CN102027368B (zh) 2008-03-21 2014-02-26 艾博特健康公司 利用红细胞内含有的血红蛋白的本征色素沉着来确定血样的红细胞指数的方法及设备
JP5184697B2 (ja) 2008-03-21 2013-04-17 アボット ポイント オブ ケア インコーポレイテッド 血小板を個々に、及び凝集塊として検出及び計数するための方法及び装置
WO2009117683A2 (fr) 2008-03-21 2009-09-24 Abbott Point Of Care Procédé et appareil permettant d'analyser des cellules individuelles ou des matières particulaires par extinction de la fluorescence et/ou lixiviation
US8221985B2 (en) 2008-04-02 2012-07-17 Abbott Point Of Care, Inc. Self-calibrating gradient dilution in a constituent assay and gradient dilution apparatus performed in a thin film sample
ES2548133T3 (es) * 2008-04-09 2015-10-14 Abbott Point Of Care, Inc. Método de detección de niveles muy bajos de analito en una muestra fluida de película delgada contenida en una cámara de pequeño espesor
CA2720077C (fr) * 2008-04-09 2014-08-05 Abbott Point Of Care, Inc. Procedes de mesure de la surface d'un echantillon dispose dans une chambre d'analyse
US20100255605A1 (en) * 2009-04-02 2010-10-07 Abbott Point Of Care, Inc. Method and device for transferring biologic fluid samples
EP2519820B1 (fr) * 2009-12-31 2013-11-06 Abbott Point Of Care, Inc. Procédé et appareil pour déterminer le volume globulaire moyen des globules rouges
WO2011116305A1 (fr) 2010-03-18 2011-09-22 Abbott Point Of Care, Inc. Procédé et appareil permettant de déterminer optiquement au moins un paramètre lié à l'hémoglobine d'un échantillon de sang total
JPWO2013069749A1 (ja) * 2011-11-10 2015-04-02 興和株式会社 生物由来の生理活性物質の測定方法
JP6054758B2 (ja) * 2013-01-31 2016-12-27 シスメックス株式会社 免疫測定方法および免疫測定装置
US20190170737A1 (en) * 2016-09-19 2019-06-06 Massachusetts Institute Of Technology Systems including janus droplets
CN114235749A (zh) * 2021-12-17 2022-03-25 柏荣诊断产品（上海）有限公司 一种透散射一体法胶乳比浊试剂增敏方法
JP2024113375A (ja) * 2023-02-09 2024-08-22 日本光電工業株式会社 試料中の測定対象物を検出する免疫測定方法

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123146A (en) * 1982-06-28 1984-01-25 Abbott Lab Dual parameter flow immunoassays
EP0126450A2 (fr) * 1983-05-19 1984-11-28 Ioannis Dr. Tripatzis Particule et méthode de détection d'antigènes et/ou anticorps utilisant cette particule
EP0174195A1 (fr) * 1984-09-06 1986-03-12 The Wellcome Foundation Limited Méthodes de test diagnostiques
US5405784A (en) * 1988-11-04 1995-04-11 Chemunex Agglutination method for the determination of multiple ligands
WO2000049385A2 (fr) * 1999-02-16 2000-08-24 Coulter International Corp. Procede et appareil d'analyse des globules dans un echantillon de sang entier
WO2001096868A2 (fr) * 2000-06-12 2001-12-20 Sysmex Corporation Dosage immunologique et dispositif de dosage immunologique

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4110604A (en) * 1976-11-04 1978-08-29 Becton, Dickinson And Company Particle density measuring system
US5071774A (en) * 1983-04-05 1991-12-10 Syntex (U.S.A.) Inc. Multiparameter particle analysis
US5013150A (en) * 1988-04-01 1991-05-07 Syntex (U.S.A.) Inc. Method for detection of fluorescence or light scatter
NO164622C (no) * 1988-05-11 1990-10-24 Tore Lindmo Binaer immunometrisk partikkelbasert metode for maaling av spesifikke serum-antigener ved hjelp av vaeskestroemsmikrofotometri og et ferdigpreparert maaloppsett derav.
JP3098273B2 (ja) * 1991-05-14 2000-10-16 シスメックス株式会社 尿中の細胞分析装置
US5286452A (en) * 1991-05-20 1994-02-15 Sienna Biotech, Inc. Simultaneous multiple assays
US5422277A (en) * 1992-03-27 1995-06-06 Ortho Diagnostic Systems Inc. Cell fixative composition and method of staining cells without destroying the cell surface
AU701948B2 (en) * 1994-10-20 1999-02-11 Sysmex Corporation Reagent for analyzing solid components in urine and method for analyzing solid components by employing the same
US20020127603A1 (en) * 2000-10-12 2002-09-12 Amnis Corporation Methods for synthesizing reporter labeled beads
JP4299597B2 (ja) * 2002-07-29 2009-07-22 シスメックス株式会社 血液分析装置及び方法

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2123146A (en) * 1982-06-28 1984-01-25 Abbott Lab Dual parameter flow immunoassays
EP0126450A2 (fr) * 1983-05-19 1984-11-28 Ioannis Dr. Tripatzis Particule et méthode de détection d'antigènes et/ou anticorps utilisant cette particule
EP0174195A1 (fr) * 1984-09-06 1986-03-12 The Wellcome Foundation Limited Méthodes de test diagnostiques
US5405784A (en) * 1988-11-04 1995-04-11 Chemunex Agglutination method for the determination of multiple ligands
WO2000049385A2 (fr) * 1999-02-16 2000-08-24 Coulter International Corp. Procede et appareil d'analyse des globules dans un echantillon de sang entier
WO2001096868A2 (fr) * 2000-06-12 2001-12-20 Sysmex Corporation Dosage immunologique et dispositif de dosage immunologique

Also Published As

Publication number Publication date
ATE339687T1 (de) 2006-10-15
DE60308259D1 (de) 2006-10-26
DE60308259T2 (de) 2007-04-05
EP1365240B1 (fr) 2006-09-13
US20030224534A1 (en) 2003-12-04
EP1365240A2 (fr) 2003-11-26

Similar Documents

Publication Publication Date Title
EP1365240A3 (fr) Procédés, appareils et réactifs immunologiques
WO2006069023A3 (fr) Procede et appareil d'analyse avec effets de matrices d'echantillons reduits
WO2002079490A3 (fr) Codes-barres biologiques bases sur des particules a modification oligonucleotidique
WO2007040559A3 (fr) Dosage par electrochimiluminescence
WO2003106964A3 (fr) Procedes et dispositifs a haut rendement permettant de doser des analytes dans un echantillon fluidique
WO2007035633A3 (fr) Techniques et procedes de criblage
HK1080142A1 (en) Sensitive immunochromatographic assay
WO2004025248A3 (fr) Methodes relatives a un dosage d'une paire d'anticorps
WO2006047591A3 (fr) Dosage microfluidique rapide pour mesure quantitative d'interactions d'un ou de plusieurs analytes
WO2008051762A3 (fr) Analyse immunologique d'analytes dans des échantillons contenant des anticorps anti-analytes endogènes
WO2007011936A3 (fr) Dosage a flux lateral et dispositif utilisant des particules magnetiques
AU2002304640A1 (en) Method and diagnosis kit for selecting and or qualitative and/or quantitative detection of cells
WO2003077851A3 (fr) Composes et procedes pour analyser le proteome
EP1156329A3 (fr) Essais à modification moléculaire
WO2003092581A3 (fr) Composes de capture, recueils de ceux-ci et procedes d'analyse du proteome et compositions complexes
GB9709821D0 (en) Allergy assay
WO2008082984A3 (fr) Réactif de lyse non dénaturante destiné à être utilisé en immunoessai de capture en solution
WO2006083367A3 (fr) Dosage immunologique mettant en oeuvre une reaction d'etalonnage interne en deux etapes
WO2001098785A3 (fr) Microcircuit pour dosage immunologique base sur l'ecoulement rapide
WO2001042788A3 (fr) Bioanalyse
WO2007024633A3 (fr) Essais immunochromatogrpahiques multi-directionnels
WO2004068115A3 (fr) Procede relatif a des essais de reactions a transfert de groupe
WO2003046514A3 (fr) Dosage de ligand a base de particules au moyen d'une plage dynamique etendue
WO2006004958A3 (fr) Detection ou mesure d'anticorps par rapport a proteines antigenes dans des tissus ou des echantillons biologiques
WO2005019831A3 (fr) Procedes pour la reduction de la complexite d'un echantillon au moyen d'anticorps a des sites antigeniques de petite dimension

Legal Events

Date Code Title Description
PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

PUAL Search report despatched

Free format text: ORIGINAL CODE: 0009013

AK Designated contracting states

Kind code of ref document: A2

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

AK Designated contracting states

Kind code of ref document: A3

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

AX Request for extension of the european patent

Extension state: AL LT LV MK

RIC1 Information provided on ipc code assigned before grant

Ipc: 7G 01N 33/53 A

Ipc: 7G 01N 33/543 B

17P Request for examination filed

Effective date: 20040623

AKX Designation fees paid

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

17Q First examination report despatched

Effective date: 20041109

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LI LU MC NL PT RO SE SI SK TR

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT;WARNING: LAPSES OF ITALIAN PATENTS WITH EFFECTIVE DATE BEFORE 2007 MAY HAVE OCCURRED AT ANY TIME BEFORE 2007. THE CORRECT EFFECTIVE DATE MAY BE DIFFERENT FROM THE ONE RECORDED.

Effective date: 20060913

Ref country code: SI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: LI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: RO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: FI

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: CH

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: AT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: NL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

Ref country code: BE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

RAP1 Party data changed (applicant data changed or rights of an application transferred)

Owner name: SYSMEX CORPORATION

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REF Corresponds to:

Ref document number: 60308259

Country of ref document: DE

Date of ref document: 20061026

Kind code of ref document: P

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

Ref country code: BG

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

Ref country code: DK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061213

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061224

NLV1 Nl: lapsed or annulled due to failure to fulfill the requirements of art. 29p and 29m of the patents act
PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PT

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070302

ET Fr: translation filed
REG Reference to a national code

Ref country code: CH

Ref legal event code: PL

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

26N No opposition filed

Effective date: 20070614

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: MC

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070531

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20061214

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070521

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: EE

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: LU

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20070521

Ref country code: CY

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HU

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20070314

Ref country code: TR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20060913

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: IT

Payment date: 20100522

Year of fee payment: 8

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IT

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20110521

REG Reference to a national code

Ref country code: FR

Ref legal event code: PLFP

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: GB

Payment date: 20160518

Year of fee payment: 14

Ref country code: DE

Payment date: 20160518

Year of fee payment: 14

PGFP Annual fee paid to national office [announced via postgrant information from national office to epo]

Ref country code: FR

Payment date: 20160412

Year of fee payment: 14

REG Reference to a national code

Ref country code: DE

Ref legal event code: R119

Ref document number: 60308259

Country of ref document: DE

GBPC Gb: european patent ceased through non-payment of renewal fee

Effective date: 20170521

REG Reference to a national code

Ref country code: FR

Ref legal event code: ST

Effective date: 20180131

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GB

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170521

Ref country code: DE

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20171201

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: FR

Free format text: LAPSE BECAUSE OF NON-PAYMENT OF DUE FEES

Effective date: 20170531